Follow us twitter facebook
Edition: Global
Click here to subscribe toour free weekly newsletter click here
Industry buzz

DGLA now available in commercial quantities

Equated, a Scottish manufacturer of fatty acid compounds, has developed a method to synthetise the omega-6 fatty acid Dihomma-Gamma-Linolenic Acid (DGLA).

DGLA is well documented for its anti-inflammatory actions but, despite its interest, this substance was not easily accessible from natural source and therefore hardly available. Synthetic DGLA produced by Equated will be marketed under the trade-name EQT-101, and is now avaible for research, pharmaceutical and cosmetic industries from gram to kilogram “For anyone interested in the business of smooth healthy skin,Equateq CEO, Adam Kelliher, said.

© 2008 - Premium Beauty News -
latest news

A new trade show dedicated to clean beauty in London

Dubbed Clean Beauty in London the new trade show intends to gather experts, scientists, suppliers, brands, influencers and journalists under one roof “to build the future of clean beauty.” Taking place on October 12 & 13, 2020 at The Brewery, located at 52 Chiswell Street at the heart of London, the event aims to encourage (...)

read more
job opportunities
Experts’ views
India emerges as the next beauty giant

Asia Cosme Lab
India emerges as the next beauty giant

Thanks to a growing young population (first youth population in the world) and the emergence of a vast middle class, as well as a higher Internet connection from both urban and rural areas, India is set to emerge as the next beauty giant after China. Asia Cosme Lab took a deep dive in the fascinating Indian market, where both (...)

read more
E-shop - latest publications
United Kingdom: Premium Beauty Market Report
1700.00 € excl. tax
Safety of perfumes and cosmetics. Belarus, Kazakhstan and Russia
200.00 € excl. tax
Regulations on the registration of cosmetic products in China (part1)
135.00 € excl. tax
Go to top ↑


We use cookies to give you a better browsing experience. By continuing your visit to this site, you accept the use of cookies. Read more and set cookies